Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Biogen, Inc.
(NQ:
BIIB
)
272.20
USD
-0.68 (-0.25%)
Streaming Delayed Price
Updated: 10:13 AM EST, Mar 1, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Biogen, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
57
58
Next >
The Partnership, Inc. Launches New North Carolina Mid-Career Leadership Accelerator Program
February 25, 2021
Tags
Skills Development
NASDAQ:BIIB
Economic Growth
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program
February 24, 2021
From
GlobeNewswire News Releases
Life Sciences Cares & Biogen Foundation Help Launch Food for Free's Just Eats Program
February 24, 2021
Tags
Partnerships
Zero Hunger
Corporate Contributions
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Biogen Announces the Expiration Date Results of Its Cash Tender Offer
February 11, 2021
From
GlobeNewswire News Releases
Biogen Announces the Expiration Date Results of Its Private Exchange Offer
February 11, 2021
From
GlobeNewswire News Releases
Biogen and LabCentral Award Two Golden Tickets to Local and Innovative Science Startups
February 11, 2021
From
GlobeNewswire News Releases
Biogen Announces the Pricing Terms of its Cash Tender Offer
February 10, 2021
From
GlobeNewswire News Releases
Biogen Announces the Pricing Terms of Its Private Exchange Offer
February 10, 2021
From
GlobeNewswire News Releases
Biogen Offers Arcadia's Home Renewable Energy Program To Employees
February 05, 2021
Tags
Affordable and Clean Energy
Sustainability
Environment
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Biogen Announces Cash Tender Offer for 5.200% Senior Notes Due 2045 Open to Certain Holders Only
February 04, 2021
From
GlobeNewswire News Releases
Biogen Announces Private Exchange Offer for 5.200% Senior Notes Due 2045 Open to Certain Investors
February 04, 2021
From
GlobeNewswire News Releases
Biogen Announces FDA Approval of PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Multiple Sclerosis
February 01, 2021
From
GlobeNewswire News Releases
Thinking about trading options or stock in Pfizer, Bed Bath & Beyond, American Airlines, Biogen, or iRobot?
January 29, 2021
InvestorsObserver issues critical PriceWatch Alerts for PFE, BBBY, AAL, BIIB, and IRBT.
From
PR Newswire
Biogen and Eisai Announce FDA’s 3-Month Extension of Review Period for the Biologics License Application for Aducanumab
January 29, 2021
From
GlobeNewswire News Releases
NASDAQ:BIIB Shareholder Notice: Deadline on January 12, 2021 in Lawsuit Against Biogen Inc.
January 12, 2021
San Diego, CA -- (SBWIRE) -- 01/12/2021 -- The Shareholders Foundation announced that a deadline is coming up on January 12, 2021 in the lawsuit filed for certain investors of Biogen Inc....
From
SBWire - Latest Press Releases
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
January 12, 2021
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Biogen Inc. ("Biogen" or "the Company") (NASDAQ: BIIB) for violations of...
From
PR Newswire
BIIB FILING DEADLINE TOMORROW: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Biogen Inc.
January 11, 2021
From
GlobeNewswire News Releases
DEADLINE ALERT for TILE, BABA, and BIIB: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 11, 2021
From
GlobeNewswire News Releases
Thinking about trading options or stock in Tesla, Biogen, Crocs, Penumbra, or Baidu?
January 11, 2021
InvestorsObserver issues critical PriceWatch Alerts for TSLA, BIIB, CROX, PEN, and BIDU.
From
PR Newswire
Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors
January 11, 2021
From
GlobeNewswire News Releases
Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone
January 11, 2021
From
GlobeNewswire News Releases
Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases
January 11, 2021
Atalanta Therapeutics launches with a Series A financing exclusively by F-Prime Capital and with strategic collaborations with Biogen and Genentech.
From
Business Wire News Releases
LAWSUITS FILED AGAINST BIIB, SPLK and QSR - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
January 10, 2021
From
ACCESSWIRE
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm
January 08, 2021
From
GlobeNewswire News Releases
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen, Inc. (BIIB)
January 08, 2021
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen, Inc. (BIIB)
From
Business Wire News Releases
BIIB Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Biogen Inc. Shareholders of Class Action and Lead Plaintiff Deadline: January 12, 2021
January 08, 2021
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) and certain of its officers, on behalf of...
From
Business Wire News Releases
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen, Inc. (BIIB)
January 08, 2021
Law Offices of Howard G. Smith reminds investors of the upcoming January 12, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Biogen, Inc. ("Biogen"...
From
PR Newswire
Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec)
January 08, 2021
From
GlobeNewswire News Releases
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm
January 06, 2021
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Central...
From
Business Wire News Releases
TILE, BIIB & BABA Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm
January 06, 2021
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
57
58
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.